BIONTECH SE (BNTX)
Clinical trial NCT07069309 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-05-05 → 2026-05-01 3. primary completion date: 2026-05-05 → 2026-05-01 4. enrollment: 760 → 774 participants 5. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (69%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (20%) **Content type:** Clinical